Anika manufactures and distributes a diverse portfolio of HA-based products that cover a broad range of therapeutic applications. These products include:
Orthobiologics: Orthovisc®, Orthovisc® mini, and Monovisc™ used in the treatment of osteoarthritis; Hyalofast® for the treatment of chondral and osteochondral lesions, Hyalonect® for orthopaedic traumas and reconstruction procedures and Hyaloglide® a mechanical barrier for prevention or minimization of post surgical adhesions after tendon and peripheral nerve surgery;
Veterinary: Hyvisc® used in the treatment of equine osteoarthritis;
Dermal: Hyalomatrix® PA, Hyalofill® and Jaloskin® that are wound dressings and the Elevess™ family of cosmetic dermatology products for facial wrinkles, scar remediation and lip augmentation;
Ophthalmic: Amvisc®, Amvisc® Plus, Staarvisc™ II, and Optivisc™ injectable viscoelastic HA products for ophthalmic surgery;
Surgical: Incert®, an HA-based anti-adhesive for surgical applications;
and next-generation products for joint health and aesthetic dermatology based on the Company's proprietary, chemically modified HA.